Emergency room overutilization is a significant issue in oncology care and may increase healthcare expenditures while lowering the quality of patient care.
Emergency room (ER) overutilization is a significant issue in oncology care and may increase healthcare expenditures while lowering the quality of patient care. In reviewing the number of ER visits between January and May of 2015, researchers noticed that only 48% of visits occurred during office hours.
The goal of the study, being published in the Journal of Clinical Oncology, was to reduce ER visits by 30%. The results are also being presented at the 2016 American Society of Clinical Oncology Quality Care Symposium.
“By implementing this new system, our goal was to reduce unnecessary patient discomfort, interruptions in treatment, and financial burden,” lead study author Brian Hunis, MD, said in a statement.
The researchers introduced a quality improvement initiative in order to address the overutilization of the ER for cancer treatment side effects, calling it the plan-do-study act (PDSA). PDSA #1 focused on a phone triage system, where center staff was trained to evaluate the severity of patient systems and decide when an ER referral was appropriate, with a triage nurse available for consultation.
PDSA #2 incorporated the education of patients on chemotherapy side effects and how to handle them when office hours were closed. Patients were also provided “chemotherapy passports,” depicting the oncologist’s name, contract information, chemotherapy regimen, date of last session, and potential side effects that might warrant hospital admission. They were encouraged to call the patient access center with any questions.
Other materials were later developed: a phone triage form describing the patient’s complaint and the patient access center response, and a log describing call-ins, their data, and which of the staff members was responsible.
This initiative was implemented at Memorial Healthcare System, which includes 5 public hospitals within southern Florida. As a result of this initiative, the team saw a reduction in ER services by 60%, 4 months after implementation.
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More
Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis
January 16th 2025This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in improving treatment adherence, persistence, clinical outcomes, and patient-reported outcomes among US patients with rheumatoid arthritis.
Read More